Evidence map›Paper›PMID 36960553›Full record

ArticleJournal of primary care & community health

Mindfulness Using a Wearable Brain Sensing Device for Health Care Professionals During a Pandemic: A Pilot Program.

Karthik Ghosh, Sanjeev Nanda, Ryan T Hurt, Darrell R Schroeder, Colin P West, Karen M Fischer, Brent A Bauer, Shawn C Fokken, Ravindra Ganesh, Jennifer L Hanson and 3 more

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in Journal of primary care & community health. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04743973 (A Feasibility Study Evaluating Mindfulness-Based Intervention Assessing A Wearable Wellness Brain Sensing Device), which is not on this map. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
4.7field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04743973 nacompletednot on this map

A Feasibility Study Evaluating Mindfulness-Based Intervention Assessing A Wearable Wellness Brain Sensing Device (Muse-S) in Practicing Physicians

TypeinterventionalSponsorMayo ClinicRan2021 to 2024Enrolled40ConditionsStress, Emotional, Sleep, Quality of LifeArmsMuse S™ Headband system
3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it, 15 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 1 institution in 1 country.

Karthik GhoshMayo Clinic, Rochester, MN, USA.
Sanjeev NandaMayo Clinic, Rochester, MN, USA.
Ryan T HurtMayo Clinic, Rochester, MN, USA.
Darrell R SchroederMayo Clinic, Rochester, MN, USA.
Colin P WestMayo Clinic, Rochester, MN, USA.
Karen M FischerMayo Clinic, Rochester, MN, USA.
Brent A BauerMayo Clinic, Rochester, MN, USA.
Shawn C FokkenMayo Clinic, Rochester, MN, USA.
Ravindra GaneshMayo Clinic, Rochester, MN, USA.ORCID 0000-0002-6877-1712
Jennifer L HansonMayo Clinic, Rochester, MN, USA.
Stephanie A LindeenMayo Clinic, Rochester, MN, USA.ORCID 0000-0001-5556-1508
Sandhya PruthiMayo Clinic, Rochester, MN, USA.
Ivana T CroghanMayo Clinic, Rochester, MN, USA.ORCID 0000-0003-3464-3525
Mayo Clinic in Arizona · US

Funding

Mayo Clinic Center for Translational Science ActivitiesUL1TR000135 · NCATS · MAYO CLINIC ROCHESTER · PI KHOSLA, SUNDEEP · 2012 to 2015
$41.2M
NCATS NIH HHS UL1 TR000135
6 · The paper itself

Abstract

objectiveThe purpose of this feasibility pilot study was to evaluate safety and adherence of a wearable brain sensing wellness device designed to reduce stress among healthcare professionals (HCP).

methodsA total of 40 HCP were invited to participate in an open-label pilot study. Participants were asked to use a brain sensing wearable device (MUSE-S™) on a daily basis to reduce their stress, for a total of 90 days. Total study participation duration was 180 days. Study enrollment began in August 2021 and ended December 2021. The exploratory outcomes included stress, depression, sleep, burn-out, resilience, quality of life, and cognition.

resultsAmong the 40 HCP in study, the majority were female (85%), white (87.5%) and with an average age of 41.3 ± 11.0 years (SD). Participants used the wearable device an average of 23.8 times over a 30-day period with a mean duration of 5.8 min with each use. Study results demonstrate the positive impact of guided mindfulness using the wearable device MUSE-S™ and its accompanying application (APP). A statistically significant improvement was found for a reduction in stress (

conclusionStudy results show that 3 to 10 min of guided meditation during work hours through the use of a brain sensing wearable device is safe and acceptable, with associated health benefits for HCP.

Indexed as

MindfulnessAdultAlprostadilBrainFemaleHealth PersonnelHumansMaleMiddle AgedPandemicsPilot ProjectsQuality of LifeAlprostadilbrain sensing devicefirst responderspandemicwearable technologywellness

Identifiers

PMID36960553
PMCPMC10041582
OpenAlexW4360808254

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.